Global Robotic Biopsy Devices Market by Product Type (Systems, Instruments & Accessories), by Application (Brain, Lung, Prostate) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Industry Insights

In 2018, the global market for robotic biopsy devices was worth USD 302.5 millions. This market is expected to continue growing at a rapid pace over the forecast period. This growth can be attributed to rising cancer incidence and increasing penetration of robotic systems that diagnose this disease. Globally, cancer cases are increasing at an alarming rate. According to Cancer Research UK, there were approximately 17 million new cases of cancer in 2018. According to the Cancer Research UK, there were approximately 17 million new cancer cases in 2018. It is predicted that by 2040, there will be almost 27.5 million new cases per year.

The primary and most important test for diagnosing cancer stage is biopsy. Image-guided tests cannot detect abnormal mass growth, but they can tell if the mass is cancerous. Only a biopsy can accurately detect it. As the world's cancer burden is rising, so is the demand for these procedures. This is opening up opportunities for robotic biopsy devices.

The market is also growing because of the increasing demand for minimally invasive procedures from patients and providers. Traditional methods for performing a prostate biopsy are more complicated and require longer hospital stays. Robotic assisted devices allow specialists to obtain precise samples of any area in the prostate gland. This allows them to avoid disturbing the surrounding nerve.

Robotic biopsy provides more information about the exact location of the lesion. This decreases the chance of puncture injury to nearby tissues and organs. The robot-assisted procedure only requires 2 to 3 skin punctures regardless of how many mass samples are required for diagnosis. Because there is less invasion, there is a lower risk of infection and ultimately better recovery for patients. This has led to a greater adoption of robotic procedures than traditional ones.

Market growth may be impeded by the inaccessibility of healthcare professionals in developing countries and high costs of setting up these robotic systems. Because their healthcare costs are lower than the global average, low-income countries can't afford to purchase these costly devices. Because of low reimbursement rates, many surgeries in these countries still use manual instruments. This results in high rates of cancer mortality in these countries.

Product Type Insights

The robotic biopsy device market can be divided into two categories based on product type: systems and instruments & accessory. Instruments & Accessories accounted for 56.1% of the total revenue in 2018. The availability of many different accessories and biopsy instruments in the market is driving this segment to unprecedented growth. Additionally, as biopsies increase, so does the need for instruments like needles and brushes to perform these procedures. To reduce infection risk, each procedure requires a different set of instruments. There is an ongoing sale of accessories and instruments.

The systems segment will grow at the fastest pace during the forecast period. Robot assisted biopsy devices are being demanded by a growing number of robotics and medical device companies. This is a profitable business that these companies see due to the increasing automation of healthcare and patient demand for minimally invasive surgery. XACT Robotics has developed the XACT Robotics System. This robotic platform performs image-guided percutaneous surgeries. It is expected to launch in the U.S. by 2019. Soon, many robotic devices like Monarch Platform or Ion Endoluminal System are also expected to be available on the market.

Application Insights

Based on their application, the global robotic biopsy market is divided into the brain, prostate and lung. The market leader in lung biopsy was 2018 and will continue to dominate the market for the forecast period, with a 12.3% CAGR. Market growth is driven by the increasing incidence of lung cancer. The American Institute for Cancer Research reports that there were approximately 2 million new cases worldwide in 2018. Nearly 90% of cases are caused by smoking. Lung cancer has also been reported in non-smokers who were exposed to secondhand tobacco smoke, radon gas, or other air pollution.

Some lesions in the lungs are not obvious and can be difficult to reach. This makes it challenging to obtain a sample. This problem is solved by robot-assisted devices, which allow surgeons to extract tissue from the deepest parts of the lung with greater precision. A decrease in the procedure time leads to a shorter hospital stay and lower costs. Robot-assisted biopsies will continue to grow because of these advantages over manual procedures.

Regional Insights

Geographically, the market for robotic biopsies devices can be divided into North America and Europe, Asia Pacific and Latin America. With a market revenue of USD 175.7 millions, North America was the dominant market. The large market share is due to the presence of key players, a well-established healthcare infrastructure, as well as ongoing investments in biopsy robots.

This region is home to many medical device companies that are constantly looking at the integration of robotics and other technologies in healthcare settings in order to diagnose cancer. Intuitive Surgical, a U.S.-based medical device company, introduced a robotic platform Ion in 2019 for minimally invasive peripheral lungs biopsies. The U.S. has already licensed the device for sale.

Auris Health, a California-based company, developed the Monarch Platform robotic endoscopic system. This system is designed to detect and treat lung nodules. Only the U.S. has launched the product. Robot assisted biopsy has been a leading technology in the U.S. since the commercialization of the majority of robotic devices.

Robotic Biopsy Devices Market Share insights

Robot-assisted biopsies market is highly competitive. To increase market reach and gain a greater share, key market players are focusing their efforts on strategic consolidation. Medtronic plc and Renishaw plc are some of the major players. Intuitive Surgical and Auris Health are expected to enter this market.

The Report Covers Certain Segments

This report provides a forecast of revenue growth at the global, regional, or country level and also analyzes industry trends for each sub-segment from 2014 to 2026. GVR has divided the global robotic biopsy device market report by product type, region, and application.

• Product Type Outlook (Revenue USD Millions, 2014-2026)

  • Systems

  • Instruments & Accessories

• App Outlook (Revenue USD Million, 2014-2026)

  • Lung Biopsy

  • Brain Biopsy

  • Prostate Biopsy

  • Other Biopsies

• Regional Outlook (Revenue USD Million, 2014-2026)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

    • Spain

    • France

    • Italy

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Singapore

    • Australia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • Saudi Arabia

    • South Africa

    • UAE

Up Market Research published a new report titled “Robotic Biopsy Devices Market research report which is segmented by Product Type (Systems, Instruments & Accessories), by Application (Brain, Lung, Prostate), By Players/Companies XACT Robotics , Auris Health, Intuitive Surgical”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Robotic Biopsy Devices Market Report Segments:

The market is segmented by Product Type (Systems, Instruments & Accessories), by Application (Brain, Lung, Prostate).

Robotic Biopsy Devices Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Robotic Biopsy Devices Market

Overview of the regional outlook of the Robotic Biopsy Devices Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Robotic Biopsy Devices Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Robotic Biopsy Devices Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Systems

                2. Instruments & Accessories

                1. Brain

                2. Lung

                3. Prostate

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Robotic Biopsy Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Robotic Biopsy Devices Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.